Long-term outlook is crucial in investing, short-term gains may be attractive but can turn out to be bad if continued. AbbVie is a successful example of a newly-listed company that has turned out to b

My Best Dividend Aristocrats For August 2024

09:46pm, Tuesday, 30'th Jul 2024
The ProShares S&P 500 Dividend Aristocrats ETF slumps to end the first half of 2024, posting a loss of 1.40% in June. I present 3 strategies that can theoretically beat the dividend aristocrat index i
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Will McGough, Prime Capital Investment Advisors director of investments, joins 'Power Lunch' to discuss stock plays for three stocks.
Shares of Abbott Laboratories (ABT) came under pressure Monday after a jury in St. Louis late Friday ordered the company to pay $495 million in compensation and damages in a lawsuit over the company's
Abbott Laboratories (NYSE:ABT)) is off 3.6% to trade at $101.44 this morning, suffering a drop after its premature infant formula trial ended in the company needing to pay $495 million in damages to t
Here is my list of blue-chip stocks to research for a buy-on-weakness strategy. Each has the potential to dip by -10% to -20%, given the July S&P 500 correction expands into a more serious bear market
Abbott Labs (NYSE: ABT ) stock is falling more than 4% after a St. Louis jury found its premature infant baby formula responsible for a potentially fatal bowel disease. As of this writing, ABT stock i

Cramer's Stop Trading: Abbott Labs

10:22am, Monday, 29'th Jul 2024
CNBC's Jim Cramer explains why he is keeping an eye on shares of Abbott Laboratories.
High-yield dividend stocks are attractive investment options as they provide regular payouts regardless of market performance. Understanding dividend yield, which is a ratio showing annual dividend in
U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
Shares of Abbott Laboratories and U.K.-listed Reckitt Benckiser both drop after a Missouri jury rules against the American healthcare company.
U.K. consumer-products giant Reckitt saw its share price slump after a jury awarded $495 million in a key baby-formula case.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares tumbled 7.5% on Monday morning after a litigation decision in the US against Abbott Laboratories (NYSE:ABT) on Friday, where investors are readin
The June/July 2024 edition of Fortune 500 revealed the biggest U.S. companies by revenue and profits. Dogcatcher's quest to sniff out the best dividend buys focused on 66 industry-leaders using YChart
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE